ICON CLINICAL RESEARCH (U.K.) NO. 3 LIMITED
Get an alert when ICON CLINICAL RESEARCH (U.K.) NO. 3 LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-03-29 (in 10mo)
Last made up 2026-03-15
Watchouts
None on the register
Cash
—
Latest balance sheet
Net assets
£194K
-77.3% vs 2023
Employees
0
Average over period
Profit before tax
-£573K
-450.8% vs 2023
Name history
Renamed 1 time since incorporation
- ICON CLINICAL RESEARCH (U.K.) NO. 3 LIMITED 2021-04-19 → present
- MAPI LIMITED 2008-03-04 → 2021-04-19
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £0 | £0 | |
| Operating profit | — | — | |
| Profit before tax | £163,420 | -£573,299 | |
| Net profit | £124,983 | -£661,915 | |
| Cash | — | — | |
| Total assets less current liabilities | — | — | |
| Net assets | £856,025 | £194,110 | |
| Equity | £856,025 | £194,110 | |
| Average employees | 0 | 0 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Current ratio | 0.53x | 0.54x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Company is in a net current liability position at the year-end date. The Company meets its day to day working capital requirements through borrowings from its parent and other subsidiary group undertakings. ICON Clinical Research (U.K.) Limited, a company incorporated in the England and Wales, has indicated its support for the general obligations of the Company for a period of no less than 12 months from the date of approval of these financial statements. Having considered this support and having made reasonable enquiries, the directors are satisfied it is appropriate to prepare the financial statements on a going concern basis.”
Group structure
- ICON CLINICAL RESEARCH (U.K.) NO. 3 LIMITED · parent
- ICON Clinical Research (U.K.) No. 2 Limited 100%
Significant events
- “On 14 March 2025 Tracy Brown resigned as a director of the Company and John MacDonald was appointed as director of the Company.”
- “On 31 May 2025, the Company transferred the entire issued share capital of the ICON Clinical Research (U.K.) No. 2 Limited, comprising 2 ordinary shares, to ICON Clinical Research (U.K.) Limited, in consideration for £4,447,200 to be left outstanding as an intercompany loan.”
- “On 2 June 2025, the Company's registered address changed to 3rd Floor, North & South Wings, 100 Longwater Avenue, Green Park, Reading, Berkshire, RG2 6GP, United Kingdom.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 7 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| FOX, Erina | Secretary | 2017-07-27 | — | — |
| HOLMES, Simon | Director | 2017-07-27 | Dec 1966 | British |
| MACDONALD, John | Director | 2025-03-14 | Mar 1967 | British |
Show 7 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| KUBITZA, Daniel Raymond | Secretary | 2009-03-02 | 2012-10-31 |
| KUBITZA, Daniel Raymond | Secretary | 2008-03-04 | 2009-03-01 |
| BROWN, Tracy | Director | 2023-06-19 | 2025-03-14 |
| GLEESON, Michael | Director | 2017-07-27 | 2022-10-21 |
| KARIS, James Michael, Mr. | Director | 2014-02-27 | 2017-07-27 |
| MAIER, William Christian, Dr | Director | 2008-03-04 | 2017-07-27 |
| PAGE, Nigel Granville | Director | 2011-01-01 | 2017-07-27 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Icon Clinical Research (U.K.) Limited | Corporate entity | Shares 75–100% | 2017-11-15 | Active |
| Icon Public Limited Company | Corporate entity | Shares 75–100% | 2017-07-27 | Ceased 2017-11-15 |
| Mr Jean-Louis Marc Menard | Individual | Significant influence | 2017-05-19 | Ceased 2017-07-27 |
| Mr Bernard Marcel Jambon | Individual | Significant influence | 2017-05-19 | Ceased 2017-07-27 |
| Mr Philippe Alain Dhamelincourt | Individual | Significant influence | 2017-05-19 | Ceased 2017-07-27 |
Filing timeline
Last 20 of 90 total filings
Material constitutional events — rename, articles re-file, resolution
- 2021-04-19 RESOLUTIONS Resolution PDF
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-01-30 | AUD | auditors | Auditors resignation company | |
| 2026-01-07 | AA | accounts | Accounts with accounts type full | |
| 2025-06-02 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-03-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-03-26 | AP01 | officers | Appoint person director company with name date | |
| 2025-03-26 | TM01 | officers | Termination director company with name termination date | |
| 2024-12-16 | AA | accounts | Accounts with accounts type full | |
| 2024-03-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-03-15 | AP01 | officers | Appoint person director company with name date | |
| 2023-10-31 | AA | accounts | Accounts with accounts type full | |
| 2023-03-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-03-30 | TM01 | officers | Termination director company with name termination date | |
| 2023-01-05 | AA | accounts | Accounts with accounts type full | |
| 2022-03-31 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-03-31 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2021-12-31 | AA | accounts | Accounts with accounts type full | |
| 2021-10-05 | AD01 | address | Change registered office address company with date old address new address | |
| 2021-04-19 | RESOLUTIONS | resolution | Resolution | |
| 2021-03-31 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
—
Not reported
-
Net assets
-77.3%
£856,025 £194,110
-
Employees
—
Not reported
-
Profit before tax
-450.8%
£163,420 -£573,299
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers